205.16
+4.77
+(2.38%)
At close: April 2 at 4:00:02 PM EDT
200.16
-5.00
(-2.44%)
Pre-Market: 9:13:12 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
23,875,000
23,875,000
23,890,000
26,643,000
24,802,000
Cost of Revenue
9,669,000
9,669,000
9,856,000
10,455,000
9,563,000
Gross Profit
14,206,000
14,206,000
14,034,000
16,188,000
15,239,000
Operating Expense
9,343,000
9,343,000
8,832,000
8,652,000
8,852,000
Operating Income
4,863,000
4,863,000
5,202,000
7,536,000
6,387,000
Net Non Operating Interest Income Expense
-161,000
-161,000
17,000
-163,000
-220,000
Other Income Expense
-56,000
-56,000
-175,000
-227,000
344,000
Pretax Income
4,646,000
4,646,000
5,044,000
7,146,000
6,511,000
Tax Provision
747,000
747,000
823,000
818,000
1,064,000
Net Income Common Stockholders
3,899,000
3,899,000
4,743,000
7,103,000
6,269,000
Diluted NI Available to Com Stockholders
3,899,000
3,899,000
4,743,000
7,103,000
6,269,000
Basic EPS
5.33
--
6.44
9.80
8.77
Diluted EPS
5.29
--
6.38
9.66
8.61
Basic Average Shares
731,000
--
736,500
725,100
714,600
Diluted Average Shares
737,200
--
743,100
737,100
736,800
Total Operating Income as Reported
4,863,000
4,863,000
5,202,000
7,536,000
6,377,000
Total Expenses
19,012,000
19,012,000
18,688,000
19,107,000
18,415,000
Net Income from Continuing & Discontinued Operation
3,899,000
3,899,000
4,764,000
7,209,000
6,433,000
Normalized Income
3,946,835.34
3,946,835.34
4,373,304.12
6,568,106
5,195,900
Interest Income
117,000
117,000
303,000
41,000
11,000
Interest Expense
278,000
278,000
286,000
204,000
231,000
Net Interest Income
-161,000
-161,000
17,000
-163,000
-220,000
EBIT
4,924,000
4,924,000
5,330,000
7,350,000
6,742,000
EBITDA
7,276,000
7,276,000
7,496,000
9,482,000
8,804,000
Reconciled Cost of Revenue
9,669,000
9,669,000
9,856,000
10,455,000
9,563,000
Reconciled Depreciation
2,352,000
2,352,000
2,166,000
2,132,000
2,062,000
Net Income from Continuing Operation Net Minority Interest
3,899,000
3,899,000
4,221,000
6,328,000
5,447,000
Total Unusual Items Excluding Goodwill
-57,000
-57,000
-182,000
-271,000
300,000
Total Unusual Items
-57,000
-57,000
-182,000
-271,000
300,000
Normalized EBITDA
7,333,000
7,333,000
7,678,000
9,753,000
8,504,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9,164.66
-9,164.66
-29,695.88
-30,894
48,900
12/31/2021 - 12/29/1978
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TMO Thermo Fisher Scientific Inc.
489.06
+1.26%
IDXX IDEXX Laboratories, Inc.
426.25
+1.83%
A Agilent Technologies, Inc.
115.99
+1.70%
IQV IQVIA Holdings Inc.
174.37
+1.83%
WAT Waters Corporation
362.64
+1.87%
MEDP Medpace Holdings, Inc.
311.23
+4.53%
ILMN Illumina, Inc.
81.88
+4.45%
CRL Charles River Laboratories International, Inc.
149.28
+2.25%
MTD Mettler-Toledo International Inc.
1,172.50
+1.39%
DGX Quest Diagnostics Incorporated
167.96
-0.78%